Tuesday, October 25, 2022 9:20:43 AM
HOLLYWOOD, FL, Oct. 25, 2022 (GLOBE NEWSWIRE) -- today announced that its Board of Directors has authorized the commencement of its common stock repurchase program.
The Board has authorized aggregate common stock repurchases of up to $5 million. HCMC may purchase shares on a discretionary basis from time to time through open market purchases, privately negotiated transactions or other means, including through Rule 10b5-1 trading plans. The timing and amount of the repurchase transactions will be subject to the discretion of HCMC based upon market conditions and other opportunities that HCMC may have for the use or investment of its cash balances. The repurchase program has no expiration date, does not require the purchase of any minimum number of shares and may be suspended, modified or discontinued at any time without prior notice. The number of shares to be purchased and the timing of purchases will be based on the Company's trading windows and available liquidity, general business and market conditions, and other factors, including legal requirements, debt covenant restrictions and alternative investment opportunities.
Recent HCMC News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 09:30:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/12/2024 08:20:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 03:36:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 06:55:50 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/29/2024 05:35:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2024 09:23:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 01:30:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 09:01:10 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/23/2024 09:05:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 02:06:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:54:19 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/03/2023 09:30:49 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM